CaliPharms, Inc. (KGET)

CaliPharms Statistics

Total Valuation

CaliPharms has a market cap or net worth of 13,877.

Market Cap	13,877
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

CaliPharms has 13.88 billion shares outstanding.

Current Share Class	13.88B
Shares Outstanding	13.88B
Shares Change (YoY)	n/a
Shares Change (QoQ)	+9.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.12
PB Ratio	-0.00
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.00

Current Ratio	0.00
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.32

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	8.82%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-63.29
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.36
Average Volume (20 Days)	504,888

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.49

Income Statement

In the last 12 months, CaliPharms had revenue of 112,465 and -6.31 million in losses. Loss per share was -0.00.

Revenue	112,465
Gross Profit	-30,566
Operating Income	-775,622
Pretax Income	-6.31M
Net Income	-6.31M
EBITDA	n/a
EBIT	-775,622
Loss Per Share	-0.00

Balance Sheet

The company has 17,162 in cash and 222,554 in debt, giving a net cash position of -205,392 or -0.00 per share.

Cash & Cash Equivalents	17,162
Total Debt	222,554
Net Cash	-205,392
Net Cash Per Share	-0.00
Equity (Book Value)	-8.79M
Book Value Per Share	-0.00
Working Capital	-8.79M

Cash Flow

Operating Cash Flow	-721,437
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	-27.18%
Operating Margin	-689.66%
Pretax Margin	-5,612.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CaliPharms does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31,942.59%
Shareholder Yield	-31,942.59%
Earnings Yield	-45,485.85%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CaliPharms has an Altman Z-Score of -3524.39. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3524.39
Piotroski F-Score	n/a